Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity.
Braz J Psychiatry. 2023 Nov 23. doi: 10.47626/1516-4446-2023-3315. Online ahead of print.
Braz J Psychiatry. 2023.
PMID: 37994832
Free article.
Paliperidone palmitate for refractory and clozapine-resistant schizophrenia.
Maia-de-Oliveira JP, Nunes EA, Ushirohira JM, Machado-de-Sousa JP, Bressan RA, Hallak JE.
Maia-de-Oliveira JP, et al. Among authors: ushirohira jm.
J Neuropsychiatry Clin Neurosci. 2015 Winter;27(1):e14-6. doi: 10.1176/appi.neuropsych.13120374. Epub 2014 Dec 12.
J Neuropsychiatry Clin Neurosci. 2015.
PMID: 25716490
Item in Clipboard
Clinical validity and intrarater and test-retest reliability of the Structured Clinical Interview for DSM-5 - Clinician Version (SCID-5-CV).
Osório FL, Loureiro SR, Hallak JEC, Machado-de-Sousa JP, Ushirohira JM, Baes CVW, Apolinario TD, Donadon MF, Bolsoni LM, Guimarães T, Fracon VS, Silva-Rodrigues APC, Pizeta FA, Souza RM, Sanches RF, Dos Santos RG, Martin-Santos R, Crippa JAS.
Osório FL, et al. Among authors: ushirohira jm.
Psychiatry Clin Neurosci. 2019 Dec;73(12):754-760. doi: 10.1111/pcn.12931. Epub 2019 Oct 14.
Psychiatry Clin Neurosci. 2019.
PMID: 31490607
Free article.
Item in Clipboard
Treatment-resistant schizophrenia - A RCT on the effectiveness of repeated-dose sodium nitroprusside.
Adelino MPM, Nunes MV, Nunes MFQ, Costa ER Jr, Ajub E, Mitrovitch MPB, Ushirohira JM, Quarantini LC, Hallak JCE, Lacerda ALT.
Adelino MPM, et al. Among authors: ushirohira jm.
Schizophr Res. 2021 May;231:70-72. doi: 10.1016/j.schres.2021.03.005. Epub 2021 Mar 24.
Schizophr Res. 2021.
PMID: 33773362
Clinical Trial.
Item in Clipboard
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.
Souza JDS, Zuardi AW, Guimarães FS, Osório FL, Loureiro SR, Campos AC, Hallak JEC, Dos Santos RG, Machado Silveira IL, Pereira-Lima K, Pacheco JC, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Pires-Dos-Santos I, Mechoulam R, Kapczinski F, Fonseca BAL, Esposito DLA, Andraus MH, Crippa JAS.
Souza JDS, et al. Among authors: ushirohira jm.
Front Pharmacol. 2022 Oct 3;13:856846. doi: 10.3389/fphar.2022.856846. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36263136
Free PMC article.
Item in Clipboard
Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical Trial.
Crippa JAS, Zuardi AW, Guimarães FS, Campos AC, de Lima Osório F, Loureiro SR, Dos Santos RG, Souza JDS, Ushirohira JM, Pacheco JC, Ferreira RR, Mancini Costa KC, Scomparin DS, Scarante FF, Pires-Dos-Santos I, Mechoulam R, Kapczinski F, Fonseca BAL, Esposito DLA, Pereira-Lima K, Sen S, Andraus MH, Hallak JEC; Burnout and Distress Prevention With Cannabidiol in Front-line Health Care Workers Dealing With COVID-19 (BONSAI) Trial Investigators.
Crippa JAS, et al. Among authors: ushirohira jm.
JAMA Netw Open. 2021 Aug 2;4(8):e2120603. doi: 10.1001/jamanetworkopen.2021.20603.
JAMA Netw Open. 2021.
PMID: 34387679
Free PMC article.
Item in Clipboard
Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations.
Souza JDS, Fassoni-Ribeiro M, Batista RM, Ushirohira JM, Zuardi AW, Guimarães FS, Campos AC, Osório FL, Elias D, Souza CS, Fassoni AA, Hallak JEC, Crippa JAS.
Souza JDS, et al. Among authors: ushirohira jm.
Front Pharmacol. 2022 May 19;13:881617. doi: 10.3389/fphar.2022.881617. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35662726
Free PMC article.
Item in Clipboard
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Crippa JAS, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC, Osório FL, Loureiro SR, Dos Santos RG, Souza JDS, Ushirohira JM, Ferreira RR, Mancini Costa KC, Scomparin DS, Scarante FF, Pires-Dos-Santos I, Mechoulam R, Kapczinski F, Fonseca BAL, Esposito DLA, Passos ADC, Dal Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Koenigkam-Santos M, Santos AC, Busatto Filho G, Hallak JEC.
Crippa JAS, et al. Among authors: ushirohira jm.
Cannabis Cannabinoid Res. 2022 Oct;7(5):658-669. doi: 10.1089/can.2021.0093. Epub 2021 Oct 7.
Cannabis Cannabinoid Res. 2022.
PMID: 34619044
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite